结合临床特征与患者报告结局对系统性红斑狼疮亚型进行分类
该横断面研究纳入212例系统性红斑狼疮(SLE)患者,按疾病活动度与纤维肌痛(FM)组合分为1型、2型、混合型和轻微型SLE。结果显示21%患者合并FM,其SLAQ评分、患者整体评估及自报狼疮 flare 更高,导致医患报告不一致;识别2型SLE症状可能改善医患沟通。
要点
- 合并FM的SLE患者无论疾病活动度如何,患者报告结局均更差且与医生评估不一致。
- SLE患者中疲劳、广泛疼痛、睡眠障碍和情绪障碍常见,应识别为2型SLE症状。
- SLAQ可能需根据FM严重程度量表重新解读。
核心结论
- 疲劳、广泛疼痛、睡眠障碍和情绪障碍是SLE常见症状,将其识别为2型SLE可能改善患者沟通与理解。
- 2型SLE水平影响患者对疾病的感知和自报症状,SLAQ可能需基于FM严重程度量表重新解读。
研究设计与样本
- 横断面研究,纳入大学门诊212例SLE患者,92%为女性,平均年龄45岁。
- 患者完成系统性狼疮活动问卷(SLAQ)和2011年美国风湿病学会纤维肌痛(FM)标准。
- 活动性SLE定义为SLEDAI评分≥6、临床SLEDAI评分≥4或活动性狼疮肾炎。
- 按活动性与FM组合分为4组:1型SLE(活动性无FM)、2型SLE(非活动性伴FM)、混合型SLE(活动性伴FM)、轻微型SLE(非活动性无FM)。
主要发现
- 212例患者中30%为1型SLE,8%为2型SLE,13%为混合型SLE,49%为轻微型SLE。
- 21%患者合并FM,无论SLE疾病活动度如何,其SLAQ评分、患者整体评估评分和自报狼疮flare均更高。
- 合并FM导致患者报告与医生报告测量之间的不一致。
关键数值与推荐
- 活动性SLE定义:SLEDAI评分≥6、临床SLEDAI评分≥4或活动性狼疮肾炎。
- FM评估采用2011年美国风湿病学会纤维肌痛标准。
- 患者报告结局采用系统性狼疮活动问卷(SLAQ)。
临床怎么用
- 临床中应识别SLE患者的疲劳、广泛疼痛、睡眠障碍和情绪障碍,考虑2型SLE分类以改善医患沟通。
- 解读SLAQ时需考虑FM严重程度,避免将FM相关症状误判为SLE活动。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The type 1 and type 2 systemic lupus erythematosus (SLE) categorization system was recently proposed to validate the patients' perspective of disease and to capture a more comprehensive spectrum of symptoms. The objective of this study was to characterize the clinical manifestations of SLE subtypes and to determine the correlation between the patient- and physician-reported measures used in the model. METHODS: This was a cross-sectional study of patients with SLE in a university clinic. Patients completed the Systemic Lupus Activity Questionnaire (SLAQ) and 2011 American College of Rheumatology fibromyalgia (FM) criteria. Active SLE was defined as Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) score ≥6, clinical SLEDAI score ≥4, or active lupus nephritis. We identified 4 groups: type 1 SLE (active SLE without FM), type 2 SLE (inactive SLE with FM), mixed SLE (active SLE with FM), and minimal SLE (inactive SLE without FM). RESULTS: In this cohort of 212 patients (92% female, mean age 45 years), 30% had type 1 SLE, 8% had type 2 SLE, 13% had mixed SLE, and 49% had minimal SLE. Regardless of SLE disease activity, patients with FM (21%), reported higher SLAQ scores, patient global assessment scores, and self-reported lupus flare that resulted in discordance between patient- and physician-reported measures. CONCLUSION: Fatigue, widespread pain, sleep dysfunction, and mood disorders are common symptoms in SLE. Identifying these symptoms as type 2 SLE may be a method to improve patient communication and understanding. The level of type 2 SLE impacts patients' perception of disease and self-reported symptoms. The SLAQ may need to be reinterpreted based on the FM severity scale.
引用
- Rogers JL, Eudy AM, Pisetsky D, et al. Using Clinical Characteristics and Patient-Reported Outcome Measures to Categorize Systemic Lupus Erythematosus Subtypes. Arthritis Care Res (Hoboken). 2021. PMID: 31909888. doi:10.1002/acr.24135
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。